Show results for
Refine by
T Cell Suppliers Serving Australia
143 companies found
based inHamburg, GERMANY
Revvity Gene Delivery (formerly SIRION Biotech) supports your cell and gene therapy development process ̶ offering solutions for early R&D all the way to clinical applications, with easy transfer of processes and assays into GMP production. ...
Supporting lentiviral vector development for cell therapies; Lentivirus is an efficient tool for fast, efficient, and cost-effective generation of stable homogeneous cell models for strong gene expression or gene ...
based inMelbourne, AUSTRALIA
Mesoblast is using its proprietary mesenchymal lineage cell technology platform to develop and commercialize innovative allogeneic cellular medicines to treat complex inflammatory diseases resistant to conventional standard of care. ...
based inRockville, MARYLAND (USA)
Since the treatment of our first oncology patient in 2015, AbelZeta has been able to build best-in-class and best-in-disease potential pipeline, leading to the licensing of two CD20-directed autologous CAR-Ts to Janssen Biotech in 2023. Our goal is ...
based inLondon, UNITED KINGDOM
Treos Bio is a clinical stage company introducing a disruptive computational technology to change the paradigm of cancer immunotherapy development by resolving the dual challenges of patient and tumor heterogeneity. We use proprietary therapeutic ...
Using our proprietary computational vaccine design technology, we have developed a PolyPEPI preventive peptide vaccine against COVID-19 (SARS-CoV-2). The design of PolyPEPI-SCoV-2 exploits our knowledge on genetic heterogeneity of individuals ...
based inSeoul, SOUTH KOREA
GI Innovation is a bio-venture company that researches and develops innovative protein new drugs through well-structured translational research. The primary research and development for GI Innovation is immuno-oncology drug and allergy disease and ...
Promotes the generation of cancer-specific effector T cell (Teff) in lymph nodes, and induces the activation and proliferation of tumor-infiltrating Teff and NK cells. Controls the ...
based inWest Sacramento, CALIFORNIA (USA)
Founded in 1985, GeminiBio serves the global biotechnology industry, from basic research to commercial production, with a focus on helping our customers accelerate the development of life-enhancing biotherapeutics by streamlining and improving their ...
GemCell Plus Xeno-Free Human Serum AB enables advanced therapy researchers and developers to streamline their workflow, allowing them to bring their end products to market quickly by providing human serum that is scalable, free of bovine components, ...
based inChatham, NEW JERSEY (USA)
Tonix is a clinical-stage biopharmaceutical company focused on developing novel therapies and vaccines to prevent and treat central nervous system disorders, immunology conditions, infectious diseases, and rare diseases. At Tonix, we are focused on ...
TNX-1850 is the planned new version of the TNX-1800 vaccine that encodes spike protein from SARS-CoV-2 BA.2 ...
based inGuro-gu, SOUTH KOREA
NanoEntek possesses a key piece of Bio-MEMS technology that seamlessly integrates biotechnology with Micro-electro Mechanical Systems(MEMS), which is heralded as the most advanced technology in the 21st century. To realize this technology, ...
based inGosselies, BELGIUM
SYnAbs was founded in 2015 as a Belgian spin-off of the Catholic University of Louvain (UCL), based on the work of Prof. Hervé Bazin, the inventor of the world's first rat myeloma cell line. SYnAbs' vision is to fill the gap on the marketplace for ...
Description : IgG1 kappa Mouse anti-rat kappa light chain. Class: monoclonal. Type: secondary. Antigen: rat kappa light chain. Host/Isotype : mouse/IgG1 ...
based inRensselaer, NEW YORK (USA)
Taconic Biosciences has been a leading provider of research models for over 65 years. Through all six decades, we've had a singular mission—to accelerate advancements in human health by providing our customers with the best animal model solutions. ...
Origin: Taconic received the NCr nude Spontaneous mutant model from NCI in 1993 after several years of random breeding. The mice were derived by hysterectomy to achieve germ-free status prior to introduction into Restricted Flora™ IBU™ ...
based inAbingdon, UNITED KINGDOM
PsiOxus is a clinical-stage company redefining therapies for solid tumors with the goal of curing patients with cancer. Our clinically validated, systemically dosed T-SIGn® viral vector platform delivers tumor-localized production of combinations of ...
Four transgenes: Producing an anti-FAP bispecific plus cytokines/chemokines. Currently in clinical trials in the US and UK. See our clinical trials page for more information. The aim of this study is to characterise the safety, tolerability and ...
based inYuseong-gu, SOUTH KOREA
We strive to become a leading biotech company that contributes to human health and well-being by providing innovative therapeutic antibodies to patients with unmet medical needs. We have been committed to developing novel antibody therapeutics since ...
PMC-402 is a monoclonal antibody that targets the human TIE2 that regulated activation, proliferation, and repolarization of Tie2 expressing macrophages, resulting in T cell activation. It binds to TIE2 expressing ...
based inMünchen, GERMANY
Massive Photonics GmbH specializes in empowering scientific research through advanced DNA-PAINT super-resolution microscopy. Their offerings include comprehensive DNA-PAINT labeling kits compatible with a wide range of primary antibodies and protein ...
based inNotting Hill, AUSTRALIA
Cartherics is developing its novel “off-the-shelf” (allogeneic) immune therapy products for the treatment of cancer based on immune killer cells. The company is developing large-scale manufacture of these CAR-iNK cells for application in human ...
This technology arms the patient’s own T cells with CARs, which enable them to “seek and destroy” cancer ...
based inSan Francisco, CALIFORNIA (USA)
We were founded with the mission of creating a world without infectious disease. We are a commercial-stage immunology company focused on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases. ...
We are exploiting the unique immunology of human cytomegalovirus, or HCMV, a commonly occurring virus in humans, as a delivery vehicle – or vector – for vaccines to potentially treat and prevent infection by pathogens that are refractory ...
based inTokyo, JAPAN
Healios will expand the possibilities for curing diseases to increase and further enrich quality of life through the development and supply of regenerative medicine products as part of the rapid progress of regenerative medicine taking place in the ...
Cancer is the leading cause of death in Japan, with approximately 90% of those deaths said to be caused by solid ...
based inAlva, UNITED KINGDOM
Omega is an international diagnostics testing business that is passionate about improving lives around the world by accurately informing health decisions. Drawing on over 30 years experience, we develop, manufacture and market pioneering diagnostic ...
VISITECT® CD4 Advanced Disease supports the identification of advanced disease in people living with HIV. VISITECT® CD4 Advanced Disease is a unique, instrument-free, rapid and disposable CD4 test benefiting patients and healthcare ...
based inAlameda, CALIFORNIA (USA)
Since its inception in 1998, AllCells, a Discovery Life Sciences Company, has focused on advancing science in an innovative, collaborative, and client-centric manner. In our corporate video, AllCells’ Founder, Jay Tong, describes his early days in ...
AllCells’ GMP Fresh Leukopak products are collected by apheresis from peripheral blood of healthy donors. Our Leukopaks contain a high concentration of lymphocyte populations, T Cells, B ...
based inGainesville, GEORGIA (US) (USA)
After years of intensive research in the field of agricultural product development and high technology feed additives, Dr. Martin R. Moreira launched DINATEC with the goal of bridging the gap between the demands of the agricultural farmer/producer ...
based inDuisburg, GERMANY
Genekam Biotechnology AG was found in 1999. It started offering DNA-Tests in 2001. From 2004, it started development of PCR kits while exporting to 5 countries, today (2015) it exports to 70 countries in the world. Genekam covers different targets ...
Genekam Human T-Cell Isolation kit: Magnetic separator, Isolation chemicals 5 ...